Development of myasthenia gravis in a patient with chronic myeloid leukemia during treatment with nilotinib
Hematology Reports · 2014
DOI: 10.4081/hr.2014.5288 ↗Kurz gefasst
Fallbericht in der Zeitschrift Hematology Reports, 2014. Verfasst von David Sanford und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Hematology, University of Western Ontario , London, ON, Canada. Die Arbeit wurde bisher 8-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Division of Hematology, University of Western Ontario , London, ON, Canada.
- Department of Oncology, University of Western Ontario , London, ON, Canada.
- Department of Oncology, University of Western Ontario , London, ON, Canada ; Department of Clinical Neurological Sciences, University of Western Ontario , London, ON, Canada.
Zitieren
APA
Sanford, D., MacDonald, M., Nicolle, M., & Xenocostas, A. (2014). Development of myasthenia gravis in a patient with chronic myeloid leukemia during treatment with nilotinib. Hematology Reports. https://doi.org/10.4081/hr.2014.5288
Vancouver
Sanford D, MacDonald M, Nicolle M, Xenocostas A. Development of myasthenia gravis in a patient with chronic myeloid leukemia during treatment with nilotinib. Hematology Reports. 2014. doi:10.4081/hr.2014.5288
BibTeX
@article{Sanford2014,
author = {Sanford, David and MacDonald, Maria and Nicolle, Michael and Xenocostas, Anargyros},
title = {Development of myasthenia gravis in a patient with chronic myeloid leukemia during treatment with nilotinib},
journal = {Hematology Reports},
year = {2014},
doi = {10.4081/hr.2014.5288}
}
EUVIMED